679 related articles for article (PubMed ID: 14587097)
1. Reduced transcription of the RB2/p130 gene in human lung cancer.
Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
[TBL] [Abstract][Full Text] [Related]
2. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
[TBL] [Abstract][Full Text] [Related]
3. pRB2/p130 target genes in non-small lung cancer cells identified by microarray analysis.
Russo G; Claudio PP; Fu Y; Stiegler P; Yu Z; Macaluso M; Giordano A
Oncogene; 2003 Oct; 22(44):6959-69. PubMed ID: 14534545
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer.
Claudio PP; Howard CM; Pacilio C; Cinti C; Romano G; Minimo C; Maraldi NM; Minna JD; Gelbert L; Leoncini L; Tosi GM; Hicheli P; Caputi M; Giordano GG; Giordano A
Cancer Res; 2000 Jan; 60(2):372-82. PubMed ID: 10667590
[TBL] [Abstract][Full Text] [Related]
5. Tumor-specific exon 1 mutations could be the 'hit event' predisposing Rb2/p130 gene to epigenetic silencing in lung cancer.
Cinti C; Macaluso M; Giordano A
Oncogene; 2005 Sep; 24(38):5821-6. PubMed ID: 16044156
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the retinoblastoma-related gene RB2/p130 in primary nasopharyngeal carcinoma.
Claudio PP; Howard CM; Fu Y; Cinti C; Califano L; Micheli P; Mercer EW; Caputi M; Giordano A
Cancer Res; 2000 Jan; 60(1):8-12. PubMed ID: 10646842
[TBL] [Abstract][Full Text] [Related]
7. Genetic alterations disrupting the nuclear localization of the retinoblastoma-related gene RB2/p130 in human tumor cell lines and primary tumors.
Cinti C; Claudio PP; Howard CM; Neri LM; Fu Y; Leoncini L; Tosi GM; Maraldi NM; Giordano A
Cancer Res; 2000 Jan; 60(2):383-9. PubMed ID: 10667591
[TBL] [Abstract][Full Text] [Related]
8. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
[TBL] [Abstract][Full Text] [Related]
9. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of the GATA genes in lung cancer.
Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV
Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625
[TBL] [Abstract][Full Text] [Related]
11. Loss of pRb2/p130 expression is associated with unfavorable clinical outcome in lung cancer.
Caputi M; Groeger AM; Esposito V; De Luca A; Masciullo V; Mancini A; Baldi F; Wolner E; Giordano A
Clin Cancer Res; 2002 Dec; 8(12):3850-6. PubMed ID: 12473599
[TBL] [Abstract][Full Text] [Related]
12. The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer.
Chen JT; Cheng YW; Chou MC; Sen-Lin T; Lai WW; Ho WL; Lee H
Clin Cancer Res; 2003 Sep; 9(11):4200-4. PubMed ID: 14519646
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of p16INK4A inactivation in non small-cell lung cancers.
Gazzeri S; Gouyer V; Vour'ch C; Brambilla C; Brambilla E
Oncogene; 1998 Jan; 16(4):497-504. PubMed ID: 9484839
[TBL] [Abstract][Full Text] [Related]
14. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
[TBL] [Abstract][Full Text] [Related]
15. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
[TBL] [Abstract][Full Text] [Related]
16. Expression of Rb2/p130 in breast and endometrial cancer: correlations with hormone receptor status.
Milde-Langosch K; Goemann C; Methner C; Rieck G; Bamberger AM; Löning T
Br J Cancer; 2001 Aug; 85(4):546-51. PubMed ID: 11506494
[TBL] [Abstract][Full Text] [Related]
17. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
[TBL] [Abstract][Full Text] [Related]
18. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.
Toyooka KO; Toyooka S; Virmani AK; Sathyanarayana UG; Euhus DM; Gilcrease M; Minna JD; Gazdar AF
Cancer Res; 2001 Jun; 61(11):4556-60. PubMed ID: 11389090
[TBL] [Abstract][Full Text] [Related]
19. Retinoblastoma-related gene RB2/p130 exons 19-22 are rarely mutated in glioblastomas.
Gonzalez-Gomez P; Bello MJ; Arjona D; Alonso ME; Lomas J; De Campos JM; Vaquero J; Isla A; Gutierrez M; Rey JA
Oncol Rep; 2002; 9(5):951-4. PubMed ID: 12168053
[TBL] [Abstract][Full Text] [Related]
20. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M
Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
